NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Author's Avatar
Dec 01, 2022

NanoVibronix, Inc. (NASDAQ%3A+NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules, of 4,800,000 shares of its common stock at a purchase price of $0.50 per share.